Kevin P Connors Net Worth

The estimated Net Worth of Kevin P Connors is at least $15.1 Million dollars as of 6 June 2016. Kevin Connors owns over 21,606 units of Cutera Inc stock worth over $449,796 and over the last 21 years Kevin sold CUTR stock worth over $14,612,084.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Kevin Connors CUTR stock SEC Form 4 insiders trading

Kevin has made over 73 trades of the Cutera Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Kevin exercised 21,606 units of CUTR stock worth $187,108 on 6 June 2016.

The largest trade Kevin's ever made was exercising 408,333 units of Cutera Inc stock on 6 February 2009 worth over $40,833. On average, Kevin trades about 20,917 units every 44 days since 2004. As of 6 June 2016 Kevin still owns at least 651,878 units of Cutera Inc stock.

You can see the complete history of Kevin Connors stock trades at the bottom of the page.

What's Kevin Connors's mailing address?

Kevin's mailing address filed with the SEC is C/O CUTERA, INC., 3240 BAYSHORE BLVD., BRISBANE, CA, 94005.

Insiders trading at Cutera Inc

Over the last 21 years, insiders at Cutera Inc have traded over $58,122,420 worth of Cutera Inc stock and bought 1,064,292 units worth $26,108,997 . The most active insiders traders include Kevin P Connors, J Daniel Plants und David A Gollnick. On average, Cutera Inc executives and independent directors trade stock every 22 days with the average trade being worth of $13,243. The most recent stock trade was executed by Michael Karavitis on 14 May 2024, trading 63,603 units of CUTR stock currently worth $165,368.

What does Cutera Inc do?

cutera was established in the san francisco bay area (brisbane) in 1998 by veteran laser and optical engineers. as the pioneer of nd:yag technology, cutera® is the trusted authority in face + body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. at cutera, we’re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. cutera’s premium portfolio of products include: xeo®, trusculpt® and excel v™. in 2014, cutera introduced two new exciting additions to their family of premium products: excel hr™ for high-speed, comfortable, hair removal and enlighten™, the industry’s first picosecond + nanosecond + 2 wavelength high-powered laser system. today, our worldwide presence is represented in 40 countries, with direct operations in north america, france, austra

Complete history of Kevin Connors stock trades at Cutera Inc

Cutera Inc executives and stock owners

Cutera Inc executives and other stock owners filed with the SEC include:

• David Mowry,
  Chief Executive Officer, Director
• R. Jason Richey,
  President
• David H. Mowry,
  CEO & Director
• Rohan Seth,
  Chief Financial Officer
• Gregory Barrett,
  Independent Director
• J. Daniel Plants,
  Independent Chairman of the Board
• Timothy O'Shea,
  Independent Director
• Joseph Whitters,
  Independent Director
• Katherine Zanotti,
  Independent Director
• J. Daniel Plants,
  Exec. Chairman
• Anne Werdan,
  Director - Investor Relations
• Darren Alch,
  Vice President, General Counsel, Secretary
• Rohan Seth,
  Chief Financial Officer
• Dr. Michael Karavitis,
  Exec. VP & Chief Technology Officer
• Jerry P Widman,
  Director
• Miguel Pardos,
  EVP, International Sales
• James A. Reinstein,
  President and CEO
• Clinton Severson,
  Director
• David B Apfelberg,
  Director
• Larry Laber,
  EVP, North America Sales
• Kevin P Connors,
  President and CEO
• David A Gollnick,
  VP of Research and Development
• Thomas John Liolios,
  VP of International
• Keith J Sullivan,
  Director
• Nicholas Sheridan Lewin,
  Director
• Sandra A. Gardiner,
  EVP & Chief Financial Officer
• Elisha W Finney,
  Director
• Guy P Nohra,
  Director
• Michael J Levernier,
  VP of Clinical Development
• Associates Iii Lp Medventure,
  10% owner
• Guy Palta California Partne...,
  
• Kathleen A Maynor,
  VP of Regulary Affairs & QA
• Associates Management Iii C...,
  10% owner
• Guy Palta Partnersalta Cali...,
  
• Dean Macfarland,
  
• Michael W Sasnett,
  
• W Mark Lortz,
  Director
• Leonard C De Benedictis,
  Chief Technology Officer
• White Annette Campbell,
  Director
• Robert John Jr Shine,
  VP of International
• Ronald J Santilli,
  CFO & VP of Finance and Admin.
• John Connors,
  VP of North American Sales
• Jeryl L Hilleman,
  Director
• Michael Karavitis,
  EVP, Chief Technology Officer
• Sheila Hopkins,
  Director
• Juliane Park,
  Director
• Janet D. Widmann,
  Director
• Kevin J Cameron,
  Director
• Stuart Drummond,
  Interim CFO
• Taylor C. Harris,
  Chief Executive Officer
• Jeffrey S Jones,
  Chief Operating Officer
• Stephana Eilene Patton,
  Chief Legal Officer